malondialdehyde has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.25) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 8 (50.00) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Buckman, TD; Sutphin, MS | 1 |
Barbeau, A; Poirier, J | 1 |
Bitzer-Quintero, OK; García, JJ; Ortiz, GG; Torres-Bugarín, O; Zamora-Perez, A; Zúñiga-González, G | 1 |
Abdel-Wahab, MH | 1 |
Beal, MF; Calingasan, NY; Cormier, K; Ferrante, RJ; Smith, K; Wille, EJ; Yang, L | 1 |
Hirai, K; Ono, S; Tokuda, E | 1 |
Kuo, WW; Liu, WH; Tsai, SJ; Yin, MC | 1 |
Li, S; Pu, XP | 1 |
Li, LF; Ma, SP; Qu, R; Xu, CL; Zhang, J | 1 |
Bao, Q; Feng, G; Jiang, J; Li, S; Zhang, Z; Zhou, L | 1 |
Hu, R; Li, K; Li, X; Lu, C; Wang, Y; Wei, Y | 1 |
Chen, H; Guan, Q; Wang, M; Wang, X; Yan, Z; Yang, L | 1 |
Burlakova, EB; Fatkullina, LD; Kozachenko, AI; Molochkina, EM; Nagler, LG | 1 |
Birla, H; Dilnashin, H; Keswani, C; Rai, SN; Rathore, AS; Singh, R; Singh, RK; Singh, SP; Singh, SS; Zahra, W | 1 |
Che, Y; Feng, X; Guo, X; He, Q; Huang, Z; Liu, Q; Peng, Z; Zhang, S; Zhu, D | 1 |
Du, J; Guo, L; Li, W; Li, Y; Qiu, J; Wang, L; Zhang, T | 1 |
16 other study(ies) available for malondialdehyde and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Effects of low selenium diets on antioxidant status and MPTP toxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Brain; Catalase; Caudate Nucleus; Diet; Dopamine; Glutathione Peroxidase; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; MPTP Poisoning; Selenium; Superoxide Dismutase; Vitamin E Deficiency | 1991 |
MPTP potentiates iron-induced lipid peroxidation without the involvement of free radicals derived from oxygen.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Cytochrome c Group; Erythrocytes; Humans; Hydrogen Peroxide; In Vitro Techniques; Iron; Lipid Peroxides; Malondialdehyde; Pentetic Acid; Pyridines | 1987 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced lipid peroxidation and DNA damage in mouse bone marrow and blood.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Blood; Bone Marrow; DNA Damage; Dopamine Agents; Erythrocytes; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Micronucleus Tests; MPTP Poisoning; Oxidative Stress | 2003 |
Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Stem; Cell Nucleus; Glutathione; Hydroquinones; Male; Malondialdehyde; Mice; MPTP Poisoning; Nerve Degeneration; Neuroprotective Agents; Superoxide Dismutase | 2005 |
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2'-Deoxyguanosine; alpha-Synuclein; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Creatine; Deoxyguanosine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Glutathione; Glutathione Disulfide; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitro Compounds; Parkinson Disease; Propionates; Rats; Rats, Inbred Lew; Tyrosine 3-Monooxygenase; Ubiquinone | 2009 |
Effects of pergolide mesilate on metallothionein mRNAs expression in a mouse model for Parkinson disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Brain; Disease Models, Animal; Dopamine Agonists; Gene Expression; Lipid Peroxidation; Malondialdehyde; Metallothionein; Mice; Mice, Inbred C57BL; Parkinson Disease; Pergolide; RNA, Messenger | 2009 |
Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antioxidants; Carnosine; Corpus Striatum; Glutathione; Humans; Interleukin-6; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitric Oxide Synthase Type II; Parkinson Disease; Tumor Necrosis Factor-alpha | 2010 |
Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Ataxia; Corpus Striatum; Disease Models, Animal; Dopamine; Glutathione Peroxidase; Kaempferols; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; Neuroprotective Agents; Parkinson Disease; Phytotherapy; Plant Extracts; Superoxide Dismutase | 2011 |
Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Brain; Brain-Derived Neurotrophic Factor; Centella; Corpus Striatum; Dopamine; Dopaminergic Neurons; Glutathione; Locomotion; Male; Malondialdehyde; MPTP Poisoning; Neuroprotective Agents; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Substantia Nigra; Triterpenes | 2013 |
Protective effect of chinonin in MPTP-induced C57BL/6 mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Gait; Glutathione; Homovanillic Acid; Male; Malondialdehyde; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Substantia Nigra; Superoxide Dismutase; Xanthones | 2014 |
Transcranial Direct Current Stimulation Ameliorates Behavioral Deficits and Reduces Oxidative Stress in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Model of Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Disease Models, Animal; Dopamine; Glutathione Peroxidase; Male; Malondialdehyde; Mental Disorders; Mice; Mice, Inbred C57BL; Oxidative Stress; Parkinson Disease; Psychomotor Performance; Superoxide Dismutase; Transcranial Direct Current Stimulation; Tyrosine 3-Monooxygenase | 2015 |
Aging-related 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurochemial and behavioral deficits and redox dysfunction: improvement by AK-7.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Behavior Rating Scale; Benzamides; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Female; Glutathione; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidation-Reduction; Parkinsonian Disorders; Sirtuin 2; Substantia Nigra; Sulfonamides | 2016 |
Structural and Functional State of Erythrocyte Membranes in Mice at Different Stages of Experimental Parkinson's Disease Induced by Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcholinesterase; Animals; Erythrocyte Membrane; Kinetics; Lipid Peroxidation; Male; Malondialdehyde; Mice, Inbred C57BL; Oxidative Stress; Parkinsonian Disorders; Superoxide Dismutase | 2017 |
Anti-inflammatory Activity of Ursolic Acid in MPTP-Induced Parkinsonian Mouse Model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antiparkinson Agents; Brain; Catalase; Fluorescent Antibody Technique; Glutathione; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Mice; Nitrites; Parkinsonian Disorders; Psychomotor Performance; Real-Time Polymerase Chain Reaction; Rotarod Performance Test; Triterpenes; Ursolic Acid | 2019 |
Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 inflammasome in MPTP-induced Parkinson disease in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Catalase; Circadian Rhythm; Corpus Striatum; Cytokines; Dopaminergic Neurons; Inflammasomes; Inflammation; Malondialdehyde; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Parkinsonian Disorders; Sesquiterpenes, Guaiane; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2020 |
Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cyclooxygenase 2; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Glutathione; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Malondialdehyde; Mice; Mice, Inbred C57BL; Naphthoquinones; Neuroinflammatory Diseases; Neurotoxins; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinson Disease; Proto-Oncogene Proteins c-akt; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2022 |